Vanda Pharmaceuticals Inc (VNDA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2200 PENNSYLVANIA AVE NW WASHINGTON, DC 20037

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.

Data as of 2021-10-17 08:53:05 -0400
Market Cap1.024 Billion Shares Outstanding55.638 Million Avg 30-day Volume360.154 Thousand
P/E Ratio31.57517 Dividend Yield EPS0.579
Price/Sales3.96 Debt to Equity1.18 EBITDA42.381 Million
Price to Book Value2.13 Forward PE34.09 Enterprise Value627.806 Million
Total Cash396.493 Million Current Debt71.989 Million Gross Profit233.623 Million
BETA1.12946 52-week High/Low21.86 / 9.99 Next Earnings Date2021-10-27 Price to Cash FLow (P/CF) 90.1048
Data provided by IEX Cloud
View SEC Filings from VNDA instead.

View recent insider trading info

Funds Holding VNDA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VNDA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

39.6 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

31.2 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JONES ARANTHAN II CHIEF CORP. AFFAIRS OFFICER

  • Officer
162,362 2021-09-15 5

MITCHELL STEPHEN RAY

  • Director
31,091 2021-09-09 3

WIJKSTROM JOAKIM SVP, CHIEF MARKETING OFFICER

  • Officer
74,552 2021-08-20 3

WILLIAMS TIMOTHY SVP & GENERAL COUNSEL

  • Officer
83,211 2021-08-16 4

MORAN KEVIN PATRICK SVP, CFO & TREASURER

  • Officer
99,931 2021-07-28 3

CHROUSOS PHAEDRA

  • Director
12,925 2021-06-14 2

DUGAN RICHARD W

  • Director
69,887 2021-06-10 2

WATKINS THOMAS

  • Director
64,505 2021-06-10 2

WARD ANNE SEMPOWSKI

  • Director
20,000 2021-06-10 1

POLYMEROPOULOS MIHAEL HRISTOS PRESIDENT AND CEO

  • Officer
  • Director
1,221,062 2021-03-08 4

BIRZNIEKS GUNTHER SVP, BUSINESS DEVELOPMENT

  • Officer
171,708 2021-03-01 2

KELLY JAMES PATRICK EVP & CHIEF FINANCIAL OFFICER

  • Officer
186,869 2020-03-02 0

REVERBERI GIAN PIERO SVP & CHIEF COMMERCIAL OFFICER

  • Officer
165,384 2020-03-02 0

COLA MICHAEL F

  • Director
15,000 2019-06-13 0

MILANO VINCENT

  • Director
10,000 2018-06-13 0

GULINO RICHARD L. SVP, GENERAL COUNSEL & SEC.

  • Officer
115,073 2018-02-28 0

BATE KENNETH

  • Director
5,000 2017-06-15 0

BAROLDI PAOLO SVP & CHIEF MEDICAL OFFICER

  • Officer
54,365 2017-01-03 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2016-09-22 0

PIEN HOWARD H

  • Director
0 2015-06-18 0

GIBBS THOMAS EDWARD SVP, CHIEF COMMERCIAL OFFICER

  • Officer
0 2015-04-20 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
3,977,773 2014-12-23 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PARTNERS, LP

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2014-12-23 0

GALSON STEVEN K

  • Director
0 2014-05-22 0

REPELLA ROBERT SVP & CHIEF COMMERCIAL OFFICER

  • Officer
15,000 2013-11-19 0

FEENEY JOHN JOSEPH SVP & CHIEF MEDICAL OFFICER

  • Officer
14,927 2012-02-16 0

KARABELAS ARGERIS N

  • Director
0 2011-06-16 0

HALAK BRIAN K

  • Director
7,276 2010-03-26 0

RAMSAY DAVID RUSS

  • FORMER DIRECTOR
0 2010-03-12 0

CLARK WILLIAM D SR. VP, CHIEF BUSINESS OFFICER

  • Officer
168,279 2010-02-19 0

IRISH STEPHANIE RAST ACTING CFO/TREASURER

  • Officer
2,249 2010-02-19 0

TANG KEVIN C

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL PARTNERS LP

  • 10% Owner
No longer subject to file 2010-01-14 0

SHALLCROSS STEVEN A SR. VP, CFO, TREASURER

  • Officer
0 2008-01-04 0

GIANCHETTI ALBERT W. SR.VP,CHIEF COMMERCIAL OFFICER

  • Officer
0 2008-01-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

JONES ARANTHAN II - Officer CHIEF CORP. AFFAIRS OFFICER

2021-09-17 08:52:04 -0400 2021-09-15 S 16,824 $16.49 d 81,980 direct -2.7139 1.8289 2.2419 5 -2.7139 2

JONES ARANTHAN II - Officer CHIEF CORP. AFFAIRS OFFICER

2021-09-17 08:52:04 -0400 2021-09-15 M 7,842 d 47,158 direct

JONES ARANTHAN II - Officer CHIEF CORP. AFFAIRS OFFICER

2021-09-17 08:52:04 -0400 2021-09-15 M 7,842 $11.32 a 98,804 direct -2.7139 1.8289 2.2419 5 -2.7139 2

JONES ARANTHAN II - Officer CHIEF CORP. AFFAIRS OFFICER

2021-09-17 08:52:04 -0400 2021-09-15 M 4,277 d 33,224 direct

JONES ARANTHAN II - Officer CHIEF CORP. AFFAIRS OFFICER

2021-09-17 08:52:04 -0400 2021-09-15 M 4,277 $12.27 a 90,962 direct -2.7139 1.8289 2.2419 5 -2.7139 2

MITCHELL STEPHEN RAY - Director

2021-09-13 16:40:15 -0400 2021-09-09 M 13,124 d 21,876 direct

MITCHELL STEPHEN RAY - Director

2021-09-13 16:40:15 -0400 2021-09-09 M 13,124 $12.70 a 28,324 direct 0.1225 1.2255 3.8603 4 -0.4289 3

MITCHELL STEPHEN RAY - Director

2021-09-13 16:40:15 -0400 2021-09-09 M 5,985 d 0 direct

MITCHELL STEPHEN RAY - Director

2021-09-13 16:40:15 -0400 2021-09-09 M 5,985 $10.57 a 15,200 direct 0.1225 1.2255 3.8603 4 -0.4289 3

MITCHELL STEPHEN RAY - Director

2021-09-13 16:40:15 -0400 2021-09-09 S 19,109 $16.74 d 9,215 direct 0.1225 1.2255 3.8603 4 -0.4289 3

WIJKSTROM JOAKIM - Officer SVP, CHIEF MARKETING OFFICER

2021-08-23 16:36:19 -0400 2021-08-20 S 3,650 $15.39 d 74,552 direct 3.8485 3.9106 11.4836 11.4836 31 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 22:15:03 UTC -0.18 0.25 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 21:45:03 UTC -0.18 0.25 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 21:15:03 UTC -0.18 0.25 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 20:45:03 UTC -0.1841 0.2541 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 20:15:03 UTC -0.1841 0.2541 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 19:45:03 UTC -0.1841 0.2541 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 19:15:03 UTC -0.1841 0.2541 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 18:45:02 UTC -0.1842 0.2542 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 18:15:03 UTC -0.1842 0.2542 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 17:45:03 UTC -0.1842 0.2542 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 17:15:03 UTC -0.1842 0.2542 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 16:45:03 UTC -0.1845 0.2545 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 16:15:03 UTC -0.1845 0.2545 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 15:45:03 UTC -0.1845 0.2545 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 15:15:03 UTC -0.1845 0.2545 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 14:45:03 UTC -0.1954 0.2654 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 14:15:03 UTC -0.1954 0.2654 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 13:45:04 UTC -0.1954 0.2654 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 13:15:03 UTC -0.1954 0.2654 1900000
VANDA PHARMACEUTICALS INC VNDA 2021-10-18 12:45:03 UTC -0.1954 0.2654 1900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments